Business Context and Reporting Period
Company: Marchex, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 8, 2009
Principal Executive Offices: Seattle, Washington
This filing reports the entry into material definitive agreements and compensatory arrangements involving executive officers and non-employee directors. The primary purpose of these agreements was to ensure documentary compliance with Section 409A of the Internal Revenue Code of 1986.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance, executive compensation, and equity grants.
Material Changes and Agreements
- Retention Agreement Amendments: Amendments were executed for executives Messrs. Arends, Caldwell, and Christothoulou to comply with Section 409A. These amendments do not generally affect the scope or amount of benefits.
- New Officer Retention Agreement: A retention agreement was entered into with Matthew Berk, designating him as an Officer and executive officer.
- Change of Control Provision: Provides a lump sum severance equal to two times the product of Annual Salary plus the greater of the prior year's bonus or the pro rata portion of the current year's bonus pool assuming maximum performance targets.
- Restricted Stock Agreement Amendments: Amendments were made for executives Messrs. Arends, Caldwell, Christothoulou, Horowitz, and Keister for Section 409A compliance without changing benefit scope.
- Executive Employment Amendment: An amendment to Michael Arends' employment agreement was executed for Section 409A compliance.
Equity Grants and Compensation
- Officer Restricted Stock Grant:
- Recipient: Peter Christothoulou (Chief Operating Officer).
- Grant Size: 325,000 shares of Class B common stock.
- Exercise Price: $0.01 per share.
- Vesting Schedule: 25% annually over four years, contingent on continued employment. Full acceleration occurs upon a Change of Control.
- Non-Employee Director Restricted Stock Grants:
- Grant Size: Aggregate of 28,600 shares of Class B common stock.
- Exercise Price: $0.01 per share.
- Vesting Schedule: 100% vested one year from the grant date, contingent on continued board service. Full acceleration occurs upon a Change of Control.
Outlook, Risks, and Contingencies
The filing does not provide forward-looking guidance, market outlook, or specific risk factors beyond the standard contingencies associated with executive compensation (e.g., Change of Control events). The agreements are qualified by reference to the full text of the forms, which will be filed as exhibits in future periodic reports.
Investor Verification Checklist
- Verify the full text of the Retention Agreement Amendments and the Berk Retention Agreement in the next applicable periodic report to confirm specific benefit calculations.
- Confirm the total number of shares authorized under the Amended and Restated 2003 Stock Incentive Plan to assess the impact of the 353,600 new shares granted (325,000 to Christothoulou + 28,600 to directors).
- Review the definition of "Change of Control" in the respective agreements to understand the acceleration triggers for the new equity grants.
- Monitor future filings for the actual vesting schedules and any potential dilution effects on existing shareholders.